Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1964 1
1966 2
1967 1
1970 2
1971 13
1972 16
1973 12
1974 17
1975 19
1976 6
1977 9
1978 10
1979 11
1980 7
1981 11
1982 11
1983 11
1984 11
1985 7
1986 5
1987 7
1988 4
1989 4
1990 10
1991 3
1992 8
1993 8
1994 17
1995 11
1996 15
1997 11
1998 17
1999 20
2000 16
2001 17
2002 15
2003 14
2004 17
2005 16
2006 14
2007 12
2008 25
2009 29
2010 34
2011 53
2012 58
2013 41
2014 35
2015 35
2016 32
2017 44
2018 42
2019 38
2020 33
2021 48
2022 20
Text availability
Article attribute
Article type
Publication date

Search Results

909 results
Results by year
Filters applied: . Clear all
Page 1
Diagnosis and management of rheumatoid arthritis.
Wasserman AM. Wasserman AM. Am Fam Physician. 2011 Dec 1;84(11):1245-52. Am Fam Physician. 2011. PMID: 22150658 Free article. Review.
Rheumatoid arthritis is the most commonly diagnosed systemic inflammatory arthritis. ...Initial laboratory evaluation should also include complete blood count with differential and assessment of renal and hepatic function. Patients taking biologic agents should be t …
Rheumatoid arthritis is the most commonly diagnosed systemic inflammatory arthritis. ...Initial laboratory evaluation should a …
Rheumatoid Arthritis: Common Questions About Diagnosis and Management.
Wasserman A. Wasserman A. Am Fam Physician. 2018 Apr 1;97(7):455-462. Am Fam Physician. 2018. PMID: 29671563 Free article.
Rheumatoid arthritis is the most commonly diagnosed systemic inflammatory arthritis, with a lifetime prevalence of up to 1% worldwide. ...Comorbid conditions, including hepatitis B or C or tuberculosis infections, must be considered when choosing medic …
Rheumatoid arthritis is the most commonly diagnosed systemic inflammatory arthritis, with a lifetime prevalence of up to 1% wo …
Viral arthritis.
Marks M, Marks JL. Marks M, et al. Clin Med (Lond). 2016 Apr;16(2):129-34. doi: 10.7861/clinmedicine.16-2-129. Clin Med (Lond). 2016. PMID: 27037381 Free PMC article. Review.
Acute-onset arthritis is a common clinical problem facing both the general clinician and the rheumatologist. ...A travel history therefore forms an important part of the assessment of patients presenting with an acute arthritis. Worldwide, parvovirus B19, hepatit …
Acute-onset arthritis is a common clinical problem facing both the general clinician and the rheumatologist. ...A travel history ther …
Tuberculosis, hepatitis B and herpes zoster in tofacitinib-treated patients with rheumatoid arthritis.
Zhang Z, Deng W, Wu Q, Sun L. Zhang Z, et al. Immunotherapy. 2019 Mar;11(4):321-333. doi: 10.2217/imt-2018-0113. Epub 2019 Jan 11. Immunotherapy. 2019. PMID: 30630365 Review.
Tofacitinib has been studied extensively in patients with rheumatoid arthritis and has been shown to be effective and generally safe. East Asian countries have a high background rate of tuberculosis (TB) and hepatitis B virus (HBV) infection and the risk of r …
Tofacitinib has been studied extensively in patients with rheumatoid arthritis and has been shown to be effective and generally safe. …
Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment.
Kuo MH, Tseng CW, Lu MC, Tung CH, Tseng KC, Huang KY, Lee CH, Lai NS. Kuo MH, et al. Dig Dis Sci. 2021 Nov;66(11):4026-4034. doi: 10.1007/s10620-020-06725-1. Epub 2021 Jan 2. Dig Dis Sci. 2021. PMID: 33387124 Free PMC article.
BACKGROUND AND AIM: To investigate the risk of hepatitis B virus reactivation in patients undergoing long-term tocilizumab therapy for rheumatoid arthritis. ...This patient was immediately treated with entecavir, which prevented hepatitis flare-up. CON …
BACKGROUND AND AIM: To investigate the risk of hepatitis B virus reactivation in patients undergoing long-term tocilizumab the …
Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib.
Wang ST, Tseng CW, Hsu CW, Tung CH, Huang KY, Lu MC, Lai NS. Wang ST, et al. Int J Rheum Dis. 2021 Nov;24(11):1362-1369. doi: 10.1111/1756-185X.14217. Epub 2021 Sep 10. Int J Rheum Dis. 2021. PMID: 34506078
OBJECTIVES: The aim of this study was to investigate hepatitis B virus (HBV) reactivation in patients with rheumatoid arthritis (RA) receiving tofacitinib. ...RESULTS: A total of 98 patients with RA were enrolled, and eight were hepatitis B surf …
OBJECTIVES: The aim of this study was to investigate hepatitis B virus (HBV) reactivation in patients with rheumatoid arthr …
Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics.
Chiu YM, Chen DY. Chiu YM, et al. Expert Rev Clin Immunol. 2020 Feb;16(2):207-228. doi: 10.1080/1744666X.2019.1705785. Epub 2020 Jan 11. Expert Rev Clin Immunol. 2020. PMID: 31852268 Review.
However, there are limited data regarding the comparison of infection risks in inflammatory arthritis patients treated with non-biologics (csDMARDs), biologics (bDMARDs), including tumor necrosis factor (TNF) inhibitors and non-TNF inhibitors, or targeted synthetic (ts)DMA …
However, there are limited data regarding the comparison of infection risks in inflammatory arthritis patients treated with non-biolo …
Multidisciplinary Approach to Prevent de novo Hepatitis B in Patients with Rheumatoid Arthritis.
Watanabe R, Igarashi T, Takahashi T, Kondo H, Okazaki S, Kudo M, Ohyanagi M, Gamoh M. Watanabe R, et al. Tohoku J Exp Med. 2020 Oct;252(2):133-141. doi: 10.1620/tjem.252.133. Tohoku J Exp Med. 2020. PMID: 33028756 Free article.
The reactivation of hepatitis B virus (HBV) in patients with rheumatoid arthritis (RA) is currently a social problem. ...In this study, medical records of patients who visited our hospital in 2011, 2015, and 2018 were retrospectively reviewed. HBV screening w …
The reactivation of hepatitis B virus (HBV) in patients with rheumatoid arthritis (RA) is currently a social problem. . …
Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review.
Thatiparthi A, Martin A, Liu J, Egeberg A, Wu JJ. Thatiparthi A, et al. Am J Clin Dermatol. 2021 Jul;22(4):425-442. doi: 10.1007/s40257-021-00603-w. Epub 2021 Apr 16. Am J Clin Dermatol. 2021. PMID: 33861409 Free PMC article. Review.
Our discussion includes the following comorbid conditions: psoriatic arthritis, multiple sclerosis, congestive heart failure, inflammatory bowel disease, hepatitis B, nonmelanoma skin cancer, lymphoma, and latent tuberculosis. ...
Our discussion includes the following comorbid conditions: psoriatic arthritis, multiple sclerosis, congestive heart failure, inflamm …
Efficacy and Safety of Hepatitis B Vaccination in Rheumatoid Arthritis Patients Receiving Disease-Modifying Antirheumatic Drugs and/or Biologics Therapy.
Intongkam S, Samakarnthai P, Pakchotanon R, Narongroeknawin P, Assavatanabodee P, Chaiamnuay S. Intongkam S, et al. J Clin Rheumatol. 2019 Dec;25(8):329-334. doi: 10.1097/RHU.0000000000000877. J Clin Rheumatol. 2019. PMID: 31764493
OBJECTIVES: The aims of this study were to assess efficacy and safety of the hepatitis B vaccination in rheumatoid arthritis (RA) patients receiving conventional and/or biological disease-modifying antirheumatic drugs (DMARDs). ...Hepatitis B va …
OBJECTIVES: The aims of this study were to assess efficacy and safety of the hepatitis B vaccination in rheumatoid arthriti …
909 results